Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Human Genetics

• Publication date

  2008-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajhg.2008.02.008PMID 18355772PMCID PMC2427217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

  2008cited by this paper
• The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

  2008cited by this paper
• Variation of breast cancer risk among BRCA1/2 carriers.

  2008influential reference
• An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

  2007influential reference
• AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

  2007cited by this paper
• Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

  2006cited by this paper
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

  2005cited by this paper
• A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes

  2005cited by this paper
• Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.

  2005cited by this paper
• EMGM Abstracts

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003influential reference
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs.

  1990cited by this paper
• Linkage strategies for genetically complex traits. I. Multilocus models.

  1990cited by this paper
• The Robust Inference for the Cox Proportional Hazards Model

  1989cited by this paper
• Programs for pedigree analysis: Mendel, Fisher, and dGene

  1988cited by this paper
• Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

  1988cited by this paper
• The behavior of maximum likelihood estimates under nonstandard conditions

  1967cited by this paper

• Nutrition-Based Paternal Influence on Gynecological Diseases in Female Offspring via Epigenetic Mechanisms

  2025cites this paper
• Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6

  2025cites this paper
• Investigation of BRCA1-BRCA2 Gene Variations in Breast Cancer Patients in the Eastern Anatolian Region of Turkey: A Study of Genetic Predisposition and Clinical Outcomes

  2025cites this paper
• Insights into genetic modifiers of breast cancer risk in carriers of BRCA1 and BRCA2 pathogenic variants

  2025cites this paper
• Decoding the Transcriptional Complexity of the Human BRCA2 DNA Repair Gene Using Hybrid-seq.

  2025cites this paper
• Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants that Confer Risk for Breast Cancer.

  2024cites this paper
• Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach

  2024cites this paper
• Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond

  2024cites this paper
• BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review

  2024cites this paper
• Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification

  2023influential citation
• Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target

  2023cites this paper
• Association of FGFR2 rs2981582 polymorphism and breast cancer susceptibility: An updated systematic review and meta-analysis

  2023cites this paper
• A New Inverse Probability of Selection Weighted Cox Model to Deal With Outcome‐Dependent Sampling in Survival Analysis

  2023cites this paper
• Epigenetic Regulation in Breast Cancer: Insights on Epidrugs

  2023cites this paper
• A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome

  2023cites this paper
• Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG

  2022cites this paper
• A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

  2022cites this paper
• Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant

  2022cites this paper
• The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

  2021cites this paper
• Hereditary Cancers and Genetics

  2021cites this paper
• A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  2021cites this paper
• The association between tri-nucleotide-repeat containing 9 (TNRC9) /LOC643714 genetic variations and breast cancer in Egyptian females

  2021cites this paper
• A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients

  2021cites this paper
• Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.

  2021cites this paper
• Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence

  2021cites this paper
• Discovery and Characterization of Cancer Genetic Susceptibility Alleles

  2020cites this paper
• Gene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges

  2020cites this paper
• Genomic Diversity in Sporadic Breast Cancer in a Latin American Population

  2020cites this paper
• Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

  2020cites this paper
• Understanding Rad51 function is a prerequisite for progress in cancer research

  2020cites this paper
• PREVALENCE OF BRCA1/BRCA2 MUTATIONS IN THE PAKISTANI BREAST CANCER PATIENTS

  2020cites this paper
• Whole exome sequencing reveals a combination of rare high and low penetrance variants that correlates with familial breast cancer relative risk

  2020cites this paper
• Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes

  2020cites this paper
• Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review

  2020cites this paper
• PIWI-interacting RNAs: new biomarkers for diagnosis and treatment of breast cancer

  2020cites this paper
• Cancers très précoces du sein et des ovaires chez les femmes porteuses d'une mutation BRCA1/2 : prévalence et influence sur l'âge du diagnostic des apparentées

  2019cites this paper
• Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women

  2019cites this paper
• Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer

  2019cites this paper
• Hereditary Endometrial and Ovarian Cancers

  2019cites this paper
• Design, synthesis and interaction of BRC4 analogous peptides with RAD51(241–260)

  2019cites this paper
• PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA

  2019cites this paper
• LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.

  2019cites this paper
• Multi-gene Panel Testing in Breast Cancer Management.

  2018cites this paper
• Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future

  2018cites this paper
• Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

  2018cites this paper
• GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

  2018cites this paper
• Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population

  2018cites this paper
• Hereditary breast cancer in South-Eastern Norway BRCA1/2- testing of breast cancer patients. Mutation spectrum and potential modifiers in Norwegian BRCA1/2 carriers

  2018cites this paper
• Epigenomic studies of twins for cancer and cancer risk factors

  2017cites this paper
• Association of genetic polymorphism with the mutation status of the BRCA1/2 genes in spontanous breast cancer

  2017influential citation
• Evaluation of the association between common genetic variants and breast cancer risk

  2017cites this paper
• Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway

  2017cites this paper
• Breast Cancer Genetics for Plastic Surgeons

  2017cites this paper
• BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

  2017cites this paper
• University of Groningen Identification of a BRCA 2-Specific Modifier Locus at 6 p 24 Related to Breast Cancer

  2017cites this paper
• Common variants at 12 p 11 , 12 q 24 , 9 p 21 , 9 q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

  2017cites this paper
• Breast Cancer Genetics

  2017cites this paper
• Virtual Screening of potential inhibitors from Herbs for the treatment of Breast Cancer

  2017cites this paper
• FGFR-targeted therapeutics for the treatment of breast cancer

  2017cites this paper
• Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

  2017cites this paper
• Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation

  2017cites this paper
• اهمیت، عملکرد و ارتباط پلیمورفیسمهای ژن TOX3 با سرطان پستان: مقاله مروری

  2017cites this paper
• Congenic and functional analysis of rat mammary cancer susceptibility.

  2016cites this paper
• Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients

  2016cites this paper
• Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes

  2016cites this paper
• The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population

  2016cites this paper
• Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.

  2016cites this paper
• Increased risk of breast cancer in individuals carrying the TNRC9 rs3803662 C>T polymorphism: a meta-analysis of case-control studies.

  2016cites this paper
• Development and application of a pathology supported pharmacogenetic test for improved clinical management of South African patients with breast cancer and associated co-morbidities

  2016cites this paper
• The LSP1 rs3817198 T > C polymorphism contributes to increased breast cancer risk: a meta-analysis of twelve studies

  2016cites this paper
• Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis

  2016cites this paper
• Association of single nucleotide polymorphism rs3803662 with the risk of breast cancer

  2016cites this paper
• THE ROLE OF MED 12 IN TUMORIGENESIS

  2016cites this paper
• Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndrome

  2016cites this paper
• Polymorphism rs144848 in BRCA2 may Reduce Lung Cancer Risk in Women: A Case-Control Study in Southeast China

  2016cites this paper
• Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis

  2016cites this paper
• The Relational Way To Dam The Flood Of Genome Data

  2015cites this paper
• Ten modifiers of BRCA1 penetrance validated in a Norwegian series

  2015influential citation
• Emerging therapeutic targets in bladder cancer.

  2015cites this paper
• Investigating the effects of Wnt/β-catenin Signalling on Melanoma Cell Metabolism and Mitochondrial Dynamics

  2015influential citation
• Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

  2015cites this paper
• Gene-panel sequencing and the prediction of breast-cancer risk.

  2015cites this paper
• The impact of known breast cancer polygenes on critical illness insurance

  2015cites this paper
• Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls

  2015cites this paper
• Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

  2015cites this paper
• Assessing the interactions between the associations of common genetic variants on 2q35 and 16q12 with breast cancer risk.

  2015cites this paper
• Leveraging Naked Mole Rat (Heterocephalus glaber) Comparative Genomics to Identify Canine Genes Modulating Susceptibility to Tumorigenesis and Cancer Phenotypes

  2015cites this paper
• Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

  2015cites this paper
• Breast Cancer Risks and Risk Prediction Models

  2015cites this paper
• RAD50:n merkitys perinnöllisessä rintasyöpäalttiudessa

  2014cites this paper
• Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

  2014cites this paper
• Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours

  2014cites this paper
• DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

  2014cites this paper
• Estimation du risque individuel de cancer du sein : intérêt et limites des modèles de calcul de risque

  2014cites this paper
• The contribution of genetic susceptibility to breast cancer

  2014cites this paper
• Breast Cancer Genomics

  2014cites this paper
• Single nucleotide polymorphisms in human health and disease: Towards resolution of a conundrum

  2014cites this paper
• Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy

  2014cites this paper
• Breast Cancer Biomarkers for Risk Assessment, Screening, Detection, Diagnosis, and Prognosis

  2014cites this paper
• Realizing the promise of cancer predisposition genes

  2014cites this paper